bioRxiv · 10.1101/2025.09.15.676273
Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia
Abstract
Chronic pain states are challenging to control with current drug therapies. Here, we demonstrate that a single dose of psilocybin can produce a sustained anti-nociceptive effect in a model of chronic neuropathic pain in male and female mice. Psilocybin anti-nociceptive effects were mediated by 5-HT2A receptors, although additional mechanisms might also be involved. Furthermore, a single dose of psilocybin caused a significant increase in the anti-nociceptive potential of gabapentin, a widely used treatment for neuropathic pain consistent with the establishment of longer lasting changes in network processing. Overall, these findings present the first preclinical evidence that psilocybin could be a valuable approach for treating chronic pain from nerve injury and serve as a new therapeutic addition for pain management.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Askey, T., Allen-Ross, D., Luzyanin, D., Lasrado, R., Gilmour, G., Hunt, S. P., Tamagnini, F., Ahmed, M., Stephens, G. J., Maiaru, M.. 2025-09-17. Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia. https://doi.org/10.1101/2025.09.15.676273
Cite the original work for its findings. Save a collection to share your selection of sources.